Email Address:
lwinter@mednet.ucla.edu
Work Email Address:
sdubinett@mednet.ucla.edu
Work Phone Number:
(310) 267-2725
Laboratory Address:
10-240 Factor
Office Address:
10833 Le Conte Ave.
CHS 37-131
Los Angeles, CA 90095
Affiliations |
Associate Vice Chancellor for Research, UCLA |
Senior Associate Dean, Translational Research, David Geffen School of Medicine at UCLA |
Professor, Medicine, Molecular & Medical Pharmacology |
Director, CTSI |
Chief, Pulmonary and Critical Care Medicine |
Division Chief, Clinical Immunology and Allergy |
Steven M. Dubinett is director of the UCLA Clinical & Translational Science Institute, Associate Vice Chancellor and Senior Associate Dean for Translational Research. He oversees the translation of UCLA biomedical discoveries into medical products and health interventions and is responsible for the efficient integration of the research infrastructure through the CTSI. He is current Chair of the Executive Committee of UC Biomedical Research Acceleration, Integration, and Development (UC BRAID), which integrates clinical and translational research across the University of California. Dr. Dubinett has extensive experience in translational investigation, academic administration, mentorship and peer review. He has trained more than 45-graduate students, post-doctoral fellows and junior faculty, nearly all of whom have continued in academic or industry research careers. Building on original discoveries relevant to inflammation and immunity in lung cancer, he developed a translational research program, which utilizes these laboratory-based discoveries in the translational and clinical environment. As a NCI Translational Research Working Group member, he participated in designing pathways to clinical goals. He previously served as Director for Biomarker Development for the American College of Surgeons Oncology Group, directing biospecimen utilization in the context of clinical trials. Dr. Dubinett serves as the Chair of the Research Evaluation Panel for biospecimen utilization for the American College of Radiology Imaging Network/ National Lung Screening Trial. He previously chaired the FDA Cellular, Tissue & Gene Therapies Advisory Committee and serves on the NCI Thoracic Malignancy Steering Committee as a Translational Science Representative.